Cargando…

Matching‐adjusted comparison of oral corticosteroid reduction in asthma: Systematic review of biologics

BACKGROUND: Oral corticosteroid (OCS) treatment for severe asthma is associated with substantial disease burden. Thus, OCS dosage reduction is desirable. Relative efficacy of biologics in reducing OCS treatment for severe, uncontrolled asthma is not fully characterized. OBJECTIVE: We performed a mat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bourdin, Arnaud, Husereau, Don, Molinari, Nicolas, Golam, Sarowar, Siddiqui, Mohd Kashif, Lindner, Leandro, Xu, Xiao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	ORIGINAL ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204869/ https://www.ncbi.nlm.nih.gov/pubmed/31943429 http://dx.doi.org/10.1111/cea.13561

Ejemplares similares

Matching-adjusted indirect comparison of benralizumab versus interleukin-5 inhibitors for the treatment of severe asthma: a systematic review
por: Bourdin, Arnaud, et al.
Publicado: (2018)

Healthcare resource utilization and costs associated with incremental systemic corticosteroid exposure in asthma
por: Voorham, Jaco, et al.
Publicado: (2018)

Short-course systemic corticosteroids in asthma: striking the balance between efficacy and safety
por: Price, David, et al.
Publicado: (2020)

The cost-effectiveness of as-needed budesonide-formoterol versus low-dose inhaled corticosteroid maintenance therapy in patients with mild asthma in Canada
por: Sadatsafavi, Mohsen, et al.
Publicado: (2021)

Systematic Literature Review of Systemic Corticosteroid Use for Asthma Management
por: Bleecker, Eugene R., et al.
Publicado: (2020)

Using biomarkers to adjust corticosteroid dose in patients with severe asthma
por: Jones, Thomas L.
Publicado: (2021)

Efficacy and Safety of Budesonide/Glycopyrronium/Formoterol Fumarate versus Other Triple Combinations in COPD: A Systematic Literature Review and Network Meta-analysis
por: Bourdin, Arnaud, et al.
Publicado: (2021)

Standard patient training versus Vik-Asthme chatbot-guided training: ‘AsthmaTrain’ – a protocol for a randomised controlled trial for patients with asthma
por: Suehs, Carey Meredith, et al.
Publicado: (2023)

Oral Corticosteroid Reduction Between Biologics Initiated and Non-Initiated Patients with Severe Asthma
por: Tanaka, Akihiko, et al.
Publicado: (2023)

How can we minimise the use of regular oral corticosteroids in asthma?
por: Bourdin, Arnaud, et al.
Publicado: (2020)

Application of an algorithm to analyze patterns of intermittent oral corticosteroid use in asthma
por: Haughney, John, et al.
Publicado: (2023)

Asthma, biologics, corticosteroids, and coronavirus disease 2019
por: Akenroye, Ayobami T., et al.
Publicado: (2020)

Biomarker-based corticosteroid adjustment in severe asthma: a modified Delphi consensus
por: Gallagher, Nicola E., et al.
Publicado: (2018)

Dupilumab is effective in type 2‐high asthma patients receiving high‐dose inhaled corticosteroids at baseline
por: Bourdin, Arnaud, et al.
Publicado: (2020)

Oral corticosteroid-sparing effects of mepolizumab in severe eosinophilic asthma: evidence from randomized controlled trials and real-world studies
por: Casale, Thomas B., et al.
Publicado: (2022)

Mepolizumab in a population with severe eosinophilic asthma and corticosteroid dependence: results from a French early access programme
por: Taillé, Camille, et al.
Publicado: (2020)

“Real-life” management of patients with severe asthma in the biologics era: Can we do better?()
por: Charriot, Jeremy, et al.
Publicado: (2021)

Adverse Outcomes, Healthcare Resource Utilization, and Costs Associated with Systemic Corticosteroid use Among Adults with Systemic Lupus Erythematosus in the UK
por: Stirnadel-Farrant, Heide A., et al.
Publicado: (2023)

Asthma and Therapeutics: Inhaled Corticosteroids, Corticosteroid Osteoporosis, and the Risk of Fracture in Chronic Asthma
por: Toogood, John H
Publicado: (2005)

An evaluation of exact matching and propensity score methods as applied in a comparative effectiveness study of inhaled corticosteroids in asthma
por: Burden, Anne, et al.
Publicado: (2017)

Observational UK cohort study to describe intermittent oral corticosteroid prescribing patterns and their association with adverse outcomes in asthma
por: Heatley, Heath, et al.
Publicado: (2023)

Transbronchial cryobiopsy in the diagnosis of interstitial lung diseases: methodologies and perspectives from the Cryo-PID and COLDICE studies
por: Suehs, Carey, et al.
Publicado: (2020)

Artificial intelligence to differentiate asthma from COPD in medico-administrative databases
por: Joumaa, Hassan, et al.
Publicado: (2022)

Corticosteroids in the treatment of acute asthma
por: Alangari, Abdullah A.
Publicado: (2014)

Asthma: beyond corticosteroid treatment
por: Marandi, Yasser, et al.
Publicado: (2013)

Inhaled Corticosteroids and Adult Asthma
por: Boulet, Louis-Philippe, et al.
Publicado: (2019)

Different Biological Pathways Between Good and Poor Inhaled Corticosteroid Responses in Asthma
por: Kim, Byung-Keun, et al.
Publicado: (2021)

Real-world benefits of biologics for asthma: Exacerbation events and systemic corticosteroid use
por: Kimura, Yuya, et al.
Publicado: (2021)

Corticosteroid tapering with benralizumab treatment for eosinophilic asthma: PONENTE Trial
por: Menzies-Gow, Andrew, et al.
Publicado: (2019)

Rising total costs and mortality rates associated with admissions due to COPD exacerbations
por: Molinari, Nicolas, et al.
Publicado: (2016)

Healthcare resource use and costs of severe, uncontrolled eosinophilic asthma in the UK general population
por: Kerkhof, Marjan, et al.
Publicado: (2018)

H(2)S donating corticosteroids: Design, synthesis and biological evaluation in a murine model of asthma
por: Corvino, Angela, et al.
Publicado: (2021)

Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI)
por: Canonica, Giorgio Walter, et al.
Publicado: (2020)

Reduction in oral corticosteroid use in patients receiving omalizumab for allergic asthma in the real-world setting
por: Braunstahl, Gert-Jan, et al.
Publicado: (2013)

Real-World Reductions in Oral Corticosteroid Use in the USA Following Mepolizumab Therapy for Severe Asthma
por: Silver, Jared, et al.
Publicado: (2020)

Inhaled Corticosteroids in Asthma and the Risk of Pneumonia
por: Kim, Min-Hye, et al.
Publicado: (2019)

Oral Corticosteroids Tapering in Severe Asthma
por: Boulet, Louis-Philippe, et al.
Publicado: (2021)

Reply to Wand et al.: Role of Transbronchial Cryobiopsy in Interstitial Lung Diseases: An Ongoing Tale
por: Bourdin, Arnaud, et al.
Publicado: (2020)

Severe, eosinophilic asthma in primary care in Canada: a longitudinal study of the clinical burden and economic impact based on linked electronic medical record data
por: Husereau, Don, et al.
Publicado: (2018)

Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids
por: Siddiqui, Salman H, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_khviv95cqgav7855fbppauq8al